References
- Heartburn across America: a Gallup Organization survey. Princeton, NJ: Gallup Organization, 1988
- Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21(11): 953–6
- Ogorek CP, Fisher RS. Detection and treatment of gastroesophageal reflux disease. Gastroenterol Clin North Am 1989; 18(2): 293–313
- Castell DO, Dalton CB, Becker D, et al. Alginic acid decreases postprandial upright gastroesophageal reflux: comparison with equal-strength antacid. Dig Dis Sci 1992; 37(4): 589–93
- Johnson DA. Medical therapy for gastroesophageal reflux disease. Am J Med 1992; 92(Suppl 5A): 88–97S
- Castell DO. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1991; 5(Suppl l): 59–67
- Russell J, Orr WC, Wilson T, et al. Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux. Aliment Pharmacol Ther 1991; 5(6): 621–30
- Hixson LJ, Kelley CL, Jones WN, et al. Current trends in the pharmacotherapy for gastroesophageal reflux disease. Arch Intern Med 1992; 152(4): 717–23
- McCallum RW, Fink SM, Winnan GR, et al. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a doubleblind trial. Am J Gastroenterol 1984; 79(3): 165–72
- Wienbeck M, Li Q. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH. Scand J Gastroenterol 1989; (Suppl 165): 13–8
- Richter JE. Efficacy of cisapride on symptoms and healing of gastrooesophageal reflux disease: a review. Scand J Gastroenterol 1989; (Suppl 165): 19–28
- Galmiche JP, Fraitag B, Filoche B, et al. Double-blind comparison of cisapride and Cimetidine in treatment of reflux esophagitis. Dig Dis Sci 1990; 35(5): 649–55
- Inauen W, Emde C, Weber B, et al. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Gut 1993; 34(8): 1025–31
- Meuwissen SG, Klinkenberg-Knol EC. Management of gastrooesophageal reflux disease: are there alternatives to omeprazole? Digestion 1989; 44(Suppl 1): 54–62
- Williams RM, Orlando RC, Bozymski EM, et al. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis. Am J Med 1987; 83(Suppl 3B): 61–6
- Fennerty MB, Castell D, Fendrick AM, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: suggested disease management guidelines. Arch Intern Med 1996; 156(5): 477–84
- Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333(17): 1106–10
- Tytgat GN, Anker Hansen OJ, Carling L, et al. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992; 27(3): 175–83
- Robinson M, Lanza F, Avner D, et al. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996; 124(10): 859–67
- Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334(16): 1018–22
- Dehn TC. Surgery for uncomplicated gastrooesophageal reflux. Gut 1992; 33(3): 293–4